Beacon Biosignals is mapping the brain during sleep

Revolutionizing Brain Study With At-Home Sleep Monitoring

Beacon Biosignals, established by MIT alumnus Jake Donoghue and former MIT researcher Jarrett Revels, is making significant strides toward better understanding the human brain. By leveraging an AI-driven platform and advanced EEG headbands worn during sleep, the company collects high-quality brain data without the need for hospital sleep labs. This allows people to sleep comfortably at home while their neurological activity is monitored in detail.

AI Unlocks Brain Health Insights

The data captured is analyzed by powerful machine-learning algorithms, which track how the brain responds to new treatments, identify early disease progression, and help group patients for clinical research. This innovative approach is especially valuable for studying diseases like major depressive disorder, schizophrenia, narcolepsy, Alzheimer’s, and Parkinson’s. Beacon’s system has already supported over 40 clinical trials worldwide.

Building the Foundation for Early Detection

Beacon Biosignals aims to build a dynamic, longitudinal dataset of brain activity. By monitoring subtle changes during sleep—including sleep architecture and micro-awakenings—the company hopes to reveal early indicators of neurodegenerative diseases long before symptoms appear. This paves the way for earlier diagnosis and more effective, personalized treatments.

Expanding Access and Impact

Following the acquisition of a leading at-home sleep apnea testing service and a substantial funding round, Beacon is scaling its reach. Their growing database means even routine sleep studies could yield valuable clues years later if a patient develops a brain disorder, turning standard testing into an essential tool for proactive neurological health.

To read the full original article, visit MIT News: Beacon Biosignals is mapping the brain during sleep.